| Farid Raphael Pourmorady, RPH | |
|
1129 S Robertson Blvd, Los Angeles, CA 90035-1403 | |
| (310) 247-0247 | |
| (310) 247-0248 |
| Full Name | Farid Raphael Pourmorady |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1129 S Robertson Blvd, Los Angeles, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003283136 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 44247 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Farid Raphael Pourmorady, RPH 1129 S Robertson Blvd, Los Angeles, CA 90035-1403 Ph: (310) 247-0247 | Farid Raphael Pourmorady, RPH 1129 S Robertson Blvd, Los Angeles, CA 90035-1403 Ph: (310) 247-0247 |
News Archive
The study, published in the Journal of Molecular Biology, shows promise in detecting potential new variants that can cause the faster spread of COVID-19. The recent mutations and variants detected have caused the rapid spread of the infection in many countries.
Cancer clinical trials with negative results don't make an immediate splash in the scientific literature, but they do have a long-term impact on cancer research, according to a new study by SWOG, the federally funded international clinical trials network.
Medivir AB (Sweden) today announced a license agreement with Daewoong Pharmaceutical Co. Ltd., (South Korea) for its hepatitis B virus (HBV) polymerase inhibitor drug, lagociclovir valactate (MIV-210).
Merrimack Pharmaceuticals, Inc., a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of serious diseases, with an initial focus on cancer, today announced the pricing of its initial public offering of 14,300,000 shares of its common stock at $7.00 per share, before underwriting discounts and commissions. All of the shares in the offering are being sold by Merrimack.
Surgery to remove multiple herniated or degenerated discs in the neck, a procedure known as anterior cervical discectomy and fusion, can be safely performed in an outpatient setting in select patients, according to a study at Hospital for Special Surgery in New York City.
› Verified 1 days ago
Robert W Cheung, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3550 S La Brea Ave, Los Angeles, CA 90016 Phone: 323-293-9397 | |
Mrs. Afaf Guirguis Karanany, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4044 Eagle Rock Blvd, Los Angeles, CA 90065 Phone: 323-254-8642 | |
Dr. Stephanie Mary Liang Luo, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1520 San Pablo St, Los Angeles, CA 90089 Phone: 213-486-8652 | |
Mr. Benjamin S Kaster, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11340 Iowa Ave Apt 8, Los Angeles, CA 90025 Phone: 310-478-6179 Fax: 310-478-6179 | |
Sarah Kim, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11321 National Blvd, Los Angeles, CA 90064 Phone: 310-479-5729 | |
Linda Han, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6041 Cadillac Ave, Kaiser West Los Angeles Medical Center, Los Angeles, CA 90034 Phone: 323-857-3989 | |
Dr. John Ball, PHARMACIST (PHARMD) Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3400 Whittier Blvd, Los Angeles, CA 90023 Phone: 562-773-3285 Fax: 323-268-1940 |